Table 1.
Data for the recovery of total cellular ATP levels in sPD fibroblast lines (mean data across 3 sPD lines) and LRRK2G2019S mutant fibroblast lines (mean data across 3 LRRK2 fibroblast lines).
| Compound | sPD | LRRK2 | ||
|---|---|---|---|---|
| Maximal Response [%] 1 | logEC50 2 | Maximal Response [%] 1 | logEC50 2 | |
| UDCA | 165 | −7.1 | 127 | −8.4 | 
| 3 | 230 | -6 | 141 | −9.3 | 
| 4 | 125 | −8.6 | 173 | −8 | 
| 7 | 132 | −8.9 | 147 | −7.7 | 
| 24 | 143 | −9.1 | 140 | −8.1 | 
1 The [%] maximal response is the maximum recovery effect of each compound reached across the nine-point concentration response curve. 2 LogEC50 give the LogEC50 concentration achieved by each compound in those lines. Compounds 4, 7 and 24 have lower EC50 concentrations in both the sPD and LRRK2 fibroblast lines compared to UDCA, whereas 3 has a higher maximal effect in both sPD and LRRK2 fibroblast lines. Indeed, all compounds have higher maximal effect than UDCA in the LRRK2 mutant fibroblasts. 100% is the DMSO vehicle-treated ATP level of the patient fibroblast lines. An increase of up to 130% would restore the ATP levels in these fibroblast lines to control levels.